Begin main content

Search

We found 52 result(s)

CDR Update — Issue 130

Last Updated: November 13, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Revised Procedure for the CADTH Common Drug Review Resubmissions In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission requirements for its Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) programs. Based on feedback from stakeholders, CADTH has implemented the proposed ...

CDR Update — Issue 129

Last Updated: October 11, 2017
Result type: Reports
Product Line: CDR Update Newsletter

In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission requirements for its Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) programs. Based on feedback from stakeholders, CADTH will be implementing the proposed revision to the resubmission eligibility criteria and a new ran...

CDR Update — Issue 128

Last Updated: September 28, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Revised Procedure for Advance Notification of Pending CDR Submissions and Resubmissions In September 2016, CADTH updated the advance notification procedure for the Common Drug Review (CDR). Since implementation, CADTH has continuously evaluated the effectiveness of the 120-day advance notification procedure and has carefully considered all fe...

CDR Update — Issue 127

Last Updated: September 11, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Extended Initiation Range for January 2018 CDEC Meeting CADTH has extended the initiation range for its Common Drug Review (CDR) submissions targeting the January 17, 2018 Canadian Drug Expert Committee (CDEC) meeting. Reviews initiated by September 20, 2017 will target the January 2018 CDEC meeting (revised from September 11, 2017). 2. Pharm...

CDR Update — Issue 126

Last Updated: August 14, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Extended Initiation Range for December 2017 CDEC Meeting CADTH has extended the initiation range for Common Drug Review (CDR) submissions targeting the December 13, 2017 Canadian Drug Expert Committee (CDEC) meeting. Reviews initiated by August 23, 2017 will target the December 2017 CDEC meeting (revised from August 14, 2017). This revision h...

CDR Update — Issue 125

Last Updated: August 1, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Sharing Patient Input Submissions for the CDR Program Since February 2014, CADTH has shared patient input submissions on our website, when permission has been given by the patient group providing the input.  Sharing the groups’ original submissions has allowed all to read how perspectives and experiences were expressed in the groups’ own word...

CDR Update — Issue 124

Last Updated: July 13, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. CDEC Meeting Added in December 2017 and Updated CDEC Meeting Dates CADTH will be holding a Canadian Drug Expert Committee (CDEC) meeting in December 2017 and has posted an updated table with the targeted CDEC meeting dates on the CADTH website. 2. CADTH Consultation: Proposed Revision to the Procedure for the CADTH Common Drug Review and the ...

CDR Update — Issue 123

Last Updated: June 13, 2017
Result type: Reports
Product Line: CDR Update Newsletter

Introducing New Patient Input Template and Integrating Companion Diagnostic Assessment Into CADTH’s Drug Review Programs CADTH would like to thank all stakeholders who responded to the consultation on the proposed changes to: the patient input template for the CADTH Common Drug Review (CDR) and the CADTH pan-Canadian Oncology Drug Review (pCODR)...

CDR Update — Issue 122

Last Updated: June 9, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Revised Advanced Notification Process for CADTH Common Drug Review 1.1 Drugs Undergoing Expedited Health Canada Review CADTH issued a new advanced notification process for the Common Drug Review (CDR) in September 2016. Stakeholders have recently communicated that it can be challenging to provide 120 days of advanced notification in situation...